Rubric Capital Management (New York)’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151M | Sell |
|
|||||
|
2025
Q1 | $172M | Hold |
|
|||||
|
2024
Q4 | $153M | Hold |
|
|||||
|
2024
Q3 | $102M | Buy |
|
|||||
|
2024
Q2 | $91.3M | Buy |
|
|||||
|
2024
Q1 | $74.4M | Buy |
|
|||||
|
2023
Q4 | $21.5M | Buy |
|
|||||
|
2023
Q3 | $26.7M | Buy |
|
|||||
|
2023
Q2 | $46.5M | Buy |
|
|||||
|
2023
Q1 | $38.5M | Buy |
|
|||||
|
2022
Q4 | $40.6M | Buy |
|
|||||
|
2022
Q3 | $9.02M | Buy |
|
|||||
|
2022
Q2 | $4.82M | Buy |
|